FDA Inspection
Swati Spentose Private LimitedSwati Spentose Private Limited – FDA Inspection, Dec 12, 2018
Record Details
This FDA Inspection record concerns Swati Spentose Private Limited, with an inspection on December 12, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 89f273ce-a3f8-4952-a9a9-976bc164c820
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1076313
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Swati Spentose Private Limited
3| Date | Classification | Office | Project area |
|---|---|---|---|
| May 31, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 12, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 26, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Swati Spentose Private Limited
- FDA Inspection 1245668 - 2024-05-31
- FDA Inspection 1037566 - 2018-01-12
- FDA Inspection 967302 - 2016-02-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.